Medi Assist Healthcare Services Limited released the transcript of its investor conference call held on May 11, 2026, to discuss audited financial results for the quarter and year ended March 31, 2026. The company delivered a strong financial performance for FY26, with operating revenue growing 25.1% year-on-year to ₹904.8 Cr. Total income for the year stood at ₹923.2 Cr, a growth of 23.6% compared to the previous year. CEO Satish Gidugu described FY26 as a "milestone year," combining strong growth with deep technology-led transformation, while CFO Sandeep Daga presented a robust balance sheet with the company turning debt-free from January 2026.

Financial Highlights

The company reported a Profit After Tax (PAT) of ₹89.3 Cr for FY26. Adjusted PAT, excluding one-time exception items net of tax impact, stood at ₹68.8 Cr. EBITDA for the year increased 13.3% to ₹174.6 Cr, with an EBITDA margin of 19.3% on operating revenue. The quarterly EBITDA margin expanded progressively, reaching 19.9% in Q4, up from 18.6% in Q3 and 17.1% in Q2.

Balance Sheet and Debt Position

Medi Assist Healthcare significantly strengthened its balance sheet during the fiscal year. The company became debt-free from January 2026, eliminating a debt position of ₹150.1 Cr from the previous year. It reported a free cash position of ₹260.5 Cr and a net worth of ₹852.4 Cr as of March 31, 2026. Contract liability stood at ₹280.2 Cr, representing committed but unearned revenue sitting in the balance sheet. Revenue per average headcount on the non-government business was ₹13.1 lakhs.

Segment-Wise Revenue Performance

The Group segment remained the primary revenue driver, while the Technology segment recorded the highest growth rate. Total premiums under management reached ₹25,923.2 Cr, growing 22.8% YoY — a figure the CEO described as a personal milestone. Group premiums exceeded ₹23,000 Cr, growing 25.6% YoY, with group premium retention at 93.2%. The company processed 100.3 Lakhs claims during the year.

Operational and Technology Highlights

Medi Assist's AI-powered platforms operated at significant scale during FY26. MAven Guard, the company's proprietary AI fraud detection platform, identified and prevented approximately ₹540 Cr in health insurance fraud during the year. The company also delivered network discounts of over ₹1,300 Cr. Raksha Prime, the flagship cashless experience offering, enabled over 3,22,000 patients to be discharged from hospitals before bills were generated, across 6,000 hospitals. The retail segment market share in the traditional TPA model stood at 5% as of March 31, 2026, while premiums managed by private insurers through the MAtrex technology platform stood at over ₹18,000 Cr, representing 32% of industry retail premiums. The company also deepened its Southeast Asia presence through a strategic partnership with Thailand's leading insurance broker, providing access to over US$50 million of group premiums in that region.

Paramount Integration and Strategic Outlook

The integration of Paramount TPA remained on track, with over 50% of Paramount Health Services' claims volume already migrated to MAtrex, with full migration to the primary processing engine targeted before Q2 of FY27. A slump transfer of Paramount TPA's operations to Medi Assist TPA was executed effective February 1, 2026, creating a single unified TPA business within the group. Management noted that quarterly margins in Q4 expanded by 130 basis points compared to Q3, and indicated the Paramount integration synergies are expected to fully materialise within one to two more quarters. On the technology monetisation front, management clarified that current technology revenues reflect only the core SaaS platform (MAtrex), with AI-led capabilities such as MAven Guard and Raksha Prime not yet contributing to reported technology revenues. Management expressed that outcome-based pricing is the directional aspiration for AI capabilities, and indicated that the technology business margin profile could potentially be one and a half to two times that of the traditional TPA business over time, though no formal guidance was provided.

Medi Assist Healthcare Services Limited's Board of Directors, at their meeting held on May 09, 2026, approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The statutory audit was conducted by M/s. MSKA & Associates LLP, whose reports carry an unmodified opinion on both standalone and consolidated financial results. The Board meeting commenced at 02:30 p.m. IST and concluded at 05:30 p.m. IST. Subsequently, pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, newspaper advertisements providing an extract of the audited financial results for the quarter and year ended March 31, 2026 were published on May 10, 2026 in 'Business Line' (English Newspaper) and 'Navshakti' (Marathi Newspaper). The trading window for dealing in shares of the Company is closed from April 01, 2026 till May 11, 2026.

Consolidated Financial Performance

Medi Assist Healthcare Services posted consolidated revenue from operations of Rs. 9,047.67 million for the year ended March 31, 2026, compared to Rs. 7,233.21 million in the previous year. Total income for the year stood at Rs. 9,232.44 million against Rs. 7,470.78 million in the prior year. On a quarterly basis, Q4 EBITDA came in at Rs. 483 million versus Rs. 407 million in the same period last year, while the Q4 EBITDA margin stood at 19.94% compared to 21.60% in the year-ago quarter. The following table summarises the key consolidated financial metrics:

Consolidated total assets as at March 31, 2026 stood at Rs. 13,724.62 million compared to Rs. 11,582.27 million as at March 31, 2025. Total equity increased to Rs. 8,524.00 million from Rs. 5,521.57 million. Net cash flows from operating activities for the year were Rs. 1,180.71 million, while net cash used in investing activities was Rs. (1,596.34) million, primarily reflecting the acquisition of Paramount Health Services & Insurance TPA Private Limited.

Standalone Financial Performance

On a standalone basis, Medi Assist Healthcare Services reported revenue from operations of Rs. 2,254.55 million for the year ended March 31, 2026, compared to Rs. 1,505.86 million in the prior year. The following table presents the key standalone financial metrics:

Standalone total assets as at March 31, 2026 stood at Rs. 5,502.91 million versus Rs. 3,311.16 million as at March 31, 2025. Total equity on a standalone basis rose to Rs. 4,893.88 million from Rs. 2,296.86 million.

Dividend Recommendation

The Board of Directors, at their meeting held on May 09, 2026, recommended a final dividend of Rs. 2 per equity share (face value Rs. 5 per share), representing 40% of face value, for the year ended March 31, 2026. The dividend is payable subject to approval by shareholders at the ensuing Annual General Meeting. The record date, as and when fixed, shall be intimated to the Stock Exchanges. Dividend shall be paid, subject to deduction of tax at source, within 30 days from the date of shareholders' approval at the ensuing AGM.

Key Corporate Developments

During the year, Medi Assist Healthcare Services completed the acquisition of 100% equity stake in Paramount Health Services and Insurance TPA Private Limited on July 01, 2025, upon payment of a purchase consideration of Rs. 4,124.40 million after closing adjustments. Paramount TPA consequently became a wholly-owned subsidiary of Medi Assist Insurance TPA Private Limited (MAITPA) and a step-down subsidiary of the Company. Additionally, on October 10, 2025, the Company allotted 37,01,000 fully paid-up equity shares at Rs. 535 per share via preferential allotment, raising an aggregate consideration of Rs. 1,980.03 million from Massachusetts Institute of Technology (28,90,830 shares; Rs. 1,546.59 million) and 238 Plan Associates LLC (8,10,170 shares; Rs. 433.44 million). As of March 31, 2026, Rs. 496.00 million of the net proceeds remained unspent. During the quarter ended March 31, 2026, the paid-up equity share capital of the Company increased from Rs. 352.61 millions to Rs. 373.05 millions, pursuant to exercise of stock options by certain employees and allotment of 385,863 equity shares and 3,701,000 equity shares by way of preferential allotment.

The consolidated results include exceptional items totalling Rs. 141.95 million for the year ended March 31, 2026, comprising: Rs. 37.68 million towards cyber-security incident costs at Paramount TPA; Rs. 33.27 million towards incremental employee benefit provisions under the New Labour Codes effective November 21, 2025; and Rs. 71.00 million towards a prudential provision made by MAITPA against advances paid to an insurance company customer pending reconciliation. Separately, on April 04, 2025, the Enforcement Directorate conducted a search and seizure operation at certain offices of MAITPA in Ranchi, Jharkhand. Management has assessed that there is no adverse impact on the Group from this matter, and no adjustment has been made in the financial results.

Other Board Decisions

Based on the recommendation of the Audit Committee, the Board approved the appointment of M/s. PricewaterhouseCoopers Services LLP as Internal Auditors of the Company for the financial year 2026-2027. PricewaterhouseCoopers Services LLP is among the leading professional services networks in the world, with more than 364,000 people in 136 countries and 137 territories, providing services across audit and assurance, tax and legal, deals and consulting. Additionally, based on the recommendation of the Nomination & Remuneration Committee, the Board reviewed certain positions operating at the group level and designated the following officials as Senior Managerial Personnel of the Company in accordance with the SEBI Listing Regulations:

Profiles of Newly Designated Senior Managerial Personnel

Ms. Vinaya Natarajan – Chief Legal Officer: Vinaya Natarajan holds a B.A., LLB (Hons) from the National Academy of Legal Studies and Research (NALSAR) and a Masters in Law from the University of London. She has over 17 years of experience in providing strategic, transactional and compliance-related support and advisory in-house to multinational companies. She has previously held senior positions with LTIMindtree, Tata Technologies, Genworks Health and the Hinduja Group.

Mr. Praveen Samariya – Chief Technology Officer: Praveen Samariya has more than 15 years of extensive experience in engineering and technology. He holds bachelor's and master's degrees in Computer Science and Engineering from the Indian Institute of Technology, Delhi. He has previously served as Head of Engineering at Mahindra Logistics, Co-Founder and CTO of AHA Taxis, and CTO and Director at SamayLa.

Mr. Dhruv Rastogi – Chief AI Officer: Dhruv Rastogi has over 16 years of experience across financial services, insurance, and marketing, operating at the intersection of business strategy, product innovation, and AI-led go-to-market execution within regulated enterprise environments. His career includes leading AI and Data Technology teams at Nomura, Edelweiss, Reliance Industries, Vodafone, Idea and IKS Health. He is an IIT Madras alumnus and has led numerous award-winning projects recognised for innovation and impact.

Earnings Call Details

Medi Assist Healthcare Services has scheduled an earnings call to discuss the audited financial results. The key details are as follows:

The following senior management members will participate in the earnings call:

Participants are encouraged to pre-register for the call to connect without waiting for operator assistance. Upon registration, participants will receive dial-in numbers, a passcode, and a pin on their registered email address. The intimation has been signed by Rashmi B V, Company Secretary & Compliance Officer (ICSI Membership No: A38729), and is available on the Company's website at www.mediassist.in .